Position in REPL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,902,340
-$514,751 QoQ
Shares Held
248,672
0.0% QoQ
Ownership
0.296%
of shares outstanding
% of Portfolio
1.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Omega Fund Management, LLC holds $129,582,182 across 8 Biotechnology names. REPL ranks #8 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BCAX |
Bicara Therapeutics Inc.
|
2,392,150 | $47,579,863 | |
| 2 | NUVB |
Nuvation Bio Inc.
|
8,081,089 | $34,667,871 | |
| 3 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
3,289,661 | $29,442,465 | |
| 4 | ENGN |
enGene Therapeutics Inc.
|
876,357 | $5,967,991 | |
| 5 | ALMS |
Alumis Inc.
|
241,255 | $5,314,847 | |
| 6 | SANA |
Sana Biotechnology, Inc.
|
843,750 | $2,430,000 | |
| 7 | IMA |
ImageneBio, Inc.
|
455,361 | $2,276,805 | |
| 8 | REPL |
Replimune Group, Inc.
This page
|
248,672 | $1,902,340 |
All Filings in REPL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,902,340 | 248,672 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,417,091 | 248,672 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,041,935 | 248,672 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $18,349,635 | 1,975,203 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $19,258,229 | 1,975,203 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $23,919,708 | 1,975,203 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $26,976,056 | 2,461,319 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $22,151,871 | 2,461,319 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $24,520,776 | 3,001,319 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $25,301,119 | 3,001,319 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $51,352,568 | 3,001,319 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $69,690,627 | 3,001,319 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $53,866,302 | 3,050,187 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $91,441,123 | 3,361,806 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $74,056,419 | 4,288,154 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $81,690,682 | 4,673,380 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $79,353,992 | 4,673,380 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $129,087,598 | 4,763,380 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $145,119,633 | 4,896,074 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $192,416,772 | 5,008,245 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $152,801,554 | 5,008,245 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $193,602,971 | 5,074,783 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $123,041,232 | 5,344,971 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $132,822,529 | 5,344,971 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $53,074,846 | 5,323,455 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||